Latest Industry Insights

Until recently, a lack of specialized services meant there was no definitive method for safely and effectively decontaminating plastic waste for reuse in new consumables. As a result, this waste was incinerated or diverted to landfill. The start-up company LabCycle has tackled this issue head-on, with its innovative approach to laboratory waste management. Technology Networks recently had the pleasure of speaking with LabCycle’s co-founder and chief technology officer Dr. Helen Liang, to learn more about its circular economy for laboratory plastic waste.

Neil Ward tells us about the role that genomics can play in conserving biodiversity and how innovative technologies such as HiFi sequencing are helping biodiversity projects.

In this interview, Erik Digman Wiklund tells us about the discovery of circRNA and discusses some of the challenges of harnessing its full potential for therapeutic interventions.

At the European Laboratory Research and Innovation Group’s (ELRIG) Research and Innovation 2024 event, we asked a selection of start-up companies in the biotech space the same question: what are the key challenges you currently face?

We spoke with Dr. Bryan Oronsky, chief development officer at EpicentRx, to discover more about the promise of multipurpose drugs and the potential of EpicentRx’s nibrozetone (RRx-001) for several conditions.

The industry's search for alternatives to traditional preclinical drug testing methods has led to a growing interest in the potential of three-dimensional (3D) in vitro models. To delve deeper into this subject, Technology Networks spoke with Madhu Lal-Nag, chief scientific officer at InSphero, a 3D in vitro model company with a mission to “modernize drug discovery in ways that inspire researchers everywhere to reach their full potential and fuel a new era of breakthrough therapies.”

Technology Networks recently connected with Vincent Pluvinage, CEO of OneD Battery Sciences, and George Schlowsky, president of Koch Modular, to shed light on the advancements of anode technology within the EV battery industry.

Scott Ripley explores how realizing the potential of mRNA therapeutics will require the standardization of processes, manufacturing agility and collaboration between industry, academia and government bodies.

John Puglia outlines and compares the capabilities offered by single-use technologies and stainless steel systems, with a focus on the flexibility of implementing SUTs.

In this interview, Dr. Mason tells us about her career path and experiences along the way, as well as sharing advice for women considering a career in science.